DIFFERENCE IN ERYTHROCYTE CATECHOL-O-METHYLTRANSFERASE ACTIVITY BETWEEN ORIENTALS AND CAUCASIANS - DIFFERENCE IN LEVODOPA TOLERANCE

被引:63
作者
RIVERACALIMLIM, L [1 ]
REILLY, DK [1 ]
机构
[1] UNIV ROCHESTER, SCH MED & DENT, DEPT PHARMACOL, ROCHESTER, NY 14642 USA
关键词
D O I
10.1038/clpt.1984.116
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:804 / 809
页数:6
相关论文
共 13 条
[1]  
AGATHOPO.A, 1971, PEDIATRICS, V47, P125
[2]  
AZELROD J, 1971, J PHARMACOL EXP THER, V176, P650
[3]  
CALNE DB, 1973, CLIN PHARMACOL THER, V14, P386
[4]  
DEAJURIAGUERRA J, 1971, NOUV PRESSE MED, V79, P1996
[5]  
FEUERSTEIN C, 1977, ACTA NEUROL SCAND, V56, P79
[6]  
MCQUEEN EG, 1980, DRUG TREATMENT, P218
[7]  
MUENTER MD, 1972, MAYO CLIN PROC, V47, P389
[8]  
MUENTER MD, 1973, MAYO CLIN PROC, V48, P173
[9]   CATECHOL-O-METHYLTRANSFERASE ACTIVITY - A DETERMINANT OF LEVODOPA RESPONSE [J].
REILLY, DK ;
RIVERACALIMLIM, L ;
VANDYKE, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :278-286
[10]   CLINICAL PICTURE AND PLASMA LEVODOPA METABOLITE PROFILE OF PARKINSONIAN NON-RESPONDERS - TREATMENT WITH LEVODOPA AND DECARBOXYLASE INHIBITOR [J].
RIVERACALIMLIM, L ;
TANDON, D ;
ANDERSON, F ;
JOYNT, R .
ARCHIVES OF NEUROLOGY, 1977, 34 (04) :228-232